Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Episodes
Diabetes Technology Updates and Standards of Care—2024
19 Dec 2023
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, d...
SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023
11 Nov 2023
Contributed by Lukas
In this episode, hosts take a deep dive into the study’s results, including secondary endpoints, and what it means for the care of patients with ove...
Tirzepatide (Zepbound) Approved for Chronic Weight Management
08 Nov 2023
Contributed by Lukas
In this episode, hosts discuss the FDA's approval of tirzeptiade (Zepbound) as an adjunct to lifestyle modification for the chronic weight management ...
Diabetes Dialogue: Automated Insulin Delivery News in October 2023
01 Nov 2023
Contributed by Lukas
In this episode, hosts discuss the FDA clearance of the Omnipod 5 App for iPhones and a pair of studies examining use of automated insulin delivery sy...
SURMOUNT-3 and SURMOUNT-4 Data
27 Oct 2023
Contributed by Lukas
In this episode, hosts discuss the results of SURMOUNT-3 and SURMOUNT-4 as well as how it might help inform use of tirzepatide if approved by the US F...
PROTECT Data and Teplizumab in Newly Diagnosed T1D
25 Oct 2023
Contributed by Lukas
In this episode, hosts discuss data from the PROTECT trial, which examined the effects of teplizumab on beta-cell function in patients with newly diag...
Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical
19 Sep 2023
Contributed by Lukas
In this episode, hosts discuss a pair of topics making headlines in recent weeks: the US Food and Drug Administration’s 510(k) clearance for the Ac...
Making Sense of Semaglutide in Type 1 Diabetes
08 Sep 2023
Contributed by Lukas
In this episode, hosts sit down for a discussion around a recent NEJM report assessing the effects of semaglutide use in people with type 1 diabetes, ...
Clearance of Tandem Mobi and Welldoc's BlueStar Platform
02 Sep 2023
Contributed by Lukas
Hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances ...
Addressing Health Disparities with Diabetes Technology, with Etty Vider, PharmD
02 Sep 2023
Contributed by Lukas
Hosts are joined by Etty Vider, PharmD, for a nuanced discussion surrounding leveraging diabetes technology to improve care for people with diabetes, ...
What Medicare Drug Price Negotiations Mean for Diabetes
29 Aug 2023
Contributed by Lukas
In this special edition episode, hosts break down what the announcement of the 10 drugs selected for Medicare price negotiations under the Inflation R...
Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD
23 Aug 2023
Contributed by Lukas
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of in...
Diabetes Dialogue: Implications of SELECT Trial and Brenzavvy on Cost Plus Drugs
23 Aug 2023
Contributed by Lukas
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexa...
Diabetes Dialogue: ADCES 2023 Recap
23 Aug 2023
Contributed by Lukas
In this episode, which is the first of multiple special edition ADCES 2023 episodes, hosts hold an overarching discussion of the meeting itself and ma...
Diabetes Dialogue: ADA 2023 Recap
23 Aug 2023
Contributed by Lukas
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to di...
Diabetes Dialogue: Latest News in Insulin Delivery, with Gary Scheiner, MS
23 Aug 2023
Contributed by Lukas
Hosts are joined by Gary Scheiner, MS, of Integrated Diabetes Services, to discuss the latest developments in diabetes technology from the floor of th...
Diabetes Dialogue: Embracing Diabetes Tech and Social Media as a Clinician, with David Ahn, MD
23 Aug 2023
Contributed by Lukas
David Ahn, MD, joins our hosts for a discussion on overcoming barriers with diabetes technology and offers perspective on his experience leveraging so...
Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric
23 Aug 2023
Contributed by Lukas
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and prov...
Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO
23 Aug 2023
Contributed by Lukas
Investigators from the TRANSITION-T2D study join Diabetes Dialogue to discuss the study and implications for care. Video version: https://www.hcplive...
Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD
23 Aug 2023
Contributed by Lukas
W. Timothy Garvey, MD, sits down to discuss the results of SURMOUNT-2, the ongoing revolution of antiobesity medications, and why he is concerned over...
Diabetes Dialogue: Improving Implementation of New Technology, with Cari Berget, RN, MPH
23 Aug 2023
Contributed by Lukas
Hosts are joined by Cari Berget, RN, MPH, for a deep dive into her efforts to improve the implementation of the latest diabetes technologies in real-w...
Diabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes
23 Aug 2023
Contributed by Lukas
Often overlooked and unrecognized, the mental health challenges accompanying type 1 diabetes are becoming a focal point of discussion for many in the ...
Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD
23 Aug 2023
Contributed by Lukas
At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to...
Diabetes Dialogue: Diabetic Foot Ulcers and Social Determinants of Health
23 Aug 2023
Contributed by Lukas
At ADA 2023, hosts sit down with Gary Rothenberg, DPM, to discuss awareness and management of diabetic foot ulcers as well as how social determinants ...
Diabetes Dialogue: What to Know about the iLet Bionic Pancreas
26 May 2023
Contributed by Lukas
As a follow-up to an episode earlier this year and the FDA clearances of the technology that forms the iLet Bionic Pancreas, hosts sat down in the MJH...
Diabetes Dialogue: Breaking Down AACE's New Type 2 Diabetes Management Algorithms
18 May 2023
Contributed by Lukas
In this special edition episode, hosts sit down for an in-depth discussion surrounding the new management algorithms from the AACE and break down how ...
Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD
12 May 2023
Contributed by Lukas
In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, inclu...
Diabetes Dialogue: SURMOUNT-2 Reaction, Omnipod GO, and Verapamil for T1D
03 May 2023
Contributed by Lukas
In this episode, hosts offer their reaction to topline data from the SURMOUNT-2 trial examining tirzepatide for weight management in T2D, the FDA's cl...
Diabetes Dialogue: CMS Expansion Ushers in New Age of CGM Access
17 Mar 2023
Contributed by Lukas
In this in-studio episode, hosts offer insight and perspective into what the news regarding the CMS expansion of CGM coverage means for people with di...
Diabetes Dialogue: ATTD 2023 Recap
03 Mar 2023
Contributed by Lukas
A recap of the top news and research from the 16th annual meeting for Advanced Technologies and Treatments for Diabetes in Berlin, Germany.
Diabetes Dialogue: Practical Updates in Pediatric Diabetes, with Stuart Weinzimer, MD
02 Mar 2023
Contributed by Lukas
In this episode, Stuart Weinzimer, MD sits down with hosts for a discussion on his research and experience with diabetes technology, the need to focus...
Diabetes Dialogue: Technology Guidelines and Uptake in Diabetes, with Grazia Aleppo, MD
01 Mar 2023
Contributed by Lukas
In this episode, hosts are joined by Grazia Aleppo, MD, to discuss the development of guideline recommendations for diabetes technology as well as her...
Diabetes Dialogue: The Role of Patient Voice in Diabetes Management
28 Feb 2023
Contributed by Lukas
In this episode, hosts are joined by Marissa Town, BSN, RN, and Renza Scibilia for a discussion centered around the role of the patient voice in diabe...
Diabetes Dialogue: Actualizing the Optimal Role of Inhaled Insulin, with Joanne Rinker, MS, RDN
28 Feb 2023
Contributed by Lukas
In this episode, hosts are joined by the associate director of Medical Affairs and Medical Education at MannKind for a special edition episode from AT...
Diabetes Dialogue: Updates in Diabetes Management from ATTD 23, with Irl Hirsch, MD
26 Feb 2023
Contributed by Lukas
In this episode, Irl Hirsch, MD, discusses a study he is conducting examining skin changes associated with insulin pump use in people with type 1 diab...
Diabetes Dialogue: Screenings for Hearing Loss in Diabetes, with Joanne Rinker, MS, RDN
25 Feb 2023
Contributed by Lukas
In this episode from ATTD 2023, hosts are joined by Joanne Rinker, MS, RDN, who provides perspective on hearing loss in diabetes, including prevalence...
Diabetes Dialogue: Mental Health and PRO Standardization, with Katharine Barnard-Kelly, PhD
25 Feb 2023
Contributed by Lukas
In this episode, hosts sit down with Katharine Barnard-Kelly, PhD, at ATTD 2023 to discuss the evolving recognition of the role of psychology in diabe...
Diabetes Dialogue: FDA Clearance of Tidepool Loop
30 Jan 2023
Contributed by Lukas
In this episode of Diabetes Dialogue, ours hosts discuss the clearance of Tidepool Loop, what is unique about the app’s customizability and compatib...
Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS
21 Jan 2023
Contributed by Lukas
In their final episode from the ADCES 2nd Annual Diabetes Technology Conference, our hosts are joined by Gary Scheiner, MS, and Jennifer Okemah, RD, t...
Diabetes Dialogue: The Prospect of a Bionic Pancreas, with Steven Russell, MD, PhD
14 Jan 2023
Contributed by Lukas
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Steven Russell, MD, PhD, the chief medical o...
Diabetes Dialogue: December 2022
23 Dec 2022
Contributed by Lukas
In the December 2022 episode, Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss recent developments in the field, with a spotlight o...
Diabetes Dialogue: The Psychology of Diabetes Management, with Jill Weissberg-Benchell, PhD
23 Dec 2022
Contributed by Lukas
In this episode of Diabetes Dialogue, Jill Weissberg-Benchell, PhD, takes hosts through her journey to becoming a diabetes care and education speciali...
Diabetes Dialogue: Updates in Inpatient Management of Diabetes, with Jane Jeffrie Seley, DNP, MPH
13 Dec 2022
Contributed by Lukas
Jane Jeffrie Seley, DNP, MPH, a member of the writing committee for the ADA's Standards of Care in Diabetes—2023, joins the podcast to discuss perti...
Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes
17 Nov 2022
Contributed by Lukas
Hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, break down what the approval of teplizumab means for type 1 diabetes. During the episode, hosts ...
Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MD
14 Nov 2022
Contributed by Lukas
In this episode, our hosts are joined by Lydia Alexander, MD, president-elect of the Obesity Medicine Association, to discuss the updates in the lands...
Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations
24 Oct 2022
Contributed by Lukas
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the ongoing GLP-1 RA shortage and whether or not...
Diabetes Dialogue: EASD 2022 and Recent CGM News
13 Oct 2022
Contributed by Lukas
In this special edition episode of Diabetes Dialogue, our hosts break down their top clinical takeaways from the European Association for the Study of...
Diabetes Dialogue: September 2022
03 Oct 2022
Contributed by Lukas
In the September 2022 episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie B...
Diabetes Dialogue: ADCES 2022 Recap
24 Aug 2022
Contributed by Lukas
In this episode of Diabetes Dialogue, which was filmed days after the conclusion of ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, ta...
Diabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD
17 Aug 2022
Contributed by Lukas
In this edition of Diabetes Dialogue, which was filmed on-site at ADCES 22, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with Jennif...
Diabetes Dialogue: Sit Down with Diabetes Care and Education Specialist of the Year, Anastasia Albanese-O'Neill, PhD
15 Aug 2022
Contributed by Lukas
In this episode, the hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down with ADCES 2022 Diabetes Care and Education Specialist of the Year...
Diabetes Dialogue: T1D Exchange, with David Walton
14 Aug 2022
Contributed by Lukas
In this ADCES 22 special edition episode of Diabetes Dialogue, our hosts are joined by David Walton, CEO of the T1D Exchange, who takes our hosts on a...
Diabetes Dialogue: Exploring DiabetesWise, with Korey Hood, PhD
14 Aug 2022
Contributed by Lukas
In this special edition of Diabetes Dialogue recorded on-site at ADCES 22, our hosts are joined by Korey Hood, PhD, a staff pscyhologist and professor...
Diabetes Dialogue: The Race to Cure T1D
29 Jul 2022
Contributed by Lukas
For the July 2022 episode of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellin...
Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, & Misdiagnosis of T1D
24 Jun 2022
Contributed by Lukas
In this edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives our hosts discuss the experiences of their prescribing tir...
Diabetes Dialogue: Inside ADA 2022
10 Jun 2022
Contributed by Lukas
In the fourth and final episode from ADA 2022, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into the meeting from their pers...
Diabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmD
09 Jun 2022
Contributed by Lukas
In the third special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, Dr. Jasmine Gonzalvo, di...
Diabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE
09 Jun 2022
Contributed by Lukas
In our second special edition episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives from ADA 2022, hosts Drs. Diana Is...
Diabetes Dialogue: Optimizing CGM Uptake in Primary Care
07 Jun 2022
Contributed by Lukas
In the first of 4 special edition ADA 2022 episodes, hosts Drs. Diana Isaacs and Natalie Bellini take on the role of interviewers and discuss CGM upta...
Diabetes Dialogue: Tirzepatide in Action & AACE 2022 Recap
20 May 2022
Contributed by Lukas
In this episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, t...
Diabetes Dialogue: ATTD 2022 Recap
06 May 2022
Contributed by Lukas
In this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Diana Isaacs, BCPS, BC...
Diabetes Dialogue: April 2022
28 Apr 2022
Contributed by Lukas
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini dis...
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
30 Mar 2022
Contributed by Lukas
The inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Belli...
Semaglutide 2.4 mg (Wegovy):A Turning Point for Obesity
25 Jun 2021
Contributed by Lukas
Ahead of ADA 2021, Dr. Thomas Wadden discusses the significance of the Wegovy approval for chronic weight management and Novo Nordisk's plans to evalu...
Subcutaneous Semaglutide for Weight Loss with Thomas Wadden, PhD
16 Mar 2021
Contributed by Lukas
This episode of the Endocrine Outlook podcast features Thomas Wadden, PhD, a professor of psychology at Perelman School of Medicine at the University ...
Tirzepatide for Weight Loss and Lowering HbA1c with Juan Frias, MD
15 Mar 2021
Contributed by Lukas
This episode of the Endocrine Outlook features a conversation with Juan Frias, MD, medical director of the National Research Institute. Frias is also ...
Dietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP
17 Feb 2021
Contributed by Lukas
In this episode, Endocrinology Network senior editor Patrick Campbell speaks with Dr. Ariana Chao, of Penn Nursing, about dietary interventions and nu...
Jeffrey Curtis, MD: Osteoporosis in 2020
07 Dec 2020
Contributed by Lukas
This episode of the Endocrine Outlook features a recent interview with Dr. Jeffrey Curtis, of the University of Alabama at Birmingham. A rheumatolog...
Osilodrostat and Treatment of Cushing's Disease
30 Oct 2020
Contributed by Lukas
Dr. Georgiana Dobri, a neuroendocrinologist with Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in...
Terri Lipman, PhD, CRNP: Addressing Racial Disparities in Medicine
29 Oct 2020
Contributed by Lukas
This episode of the Endocrine Outlook features a conversation with Terri Lipman, PhD, CRNP, of the University of Pennsylvania. In the interview, Lipma...
Raymond Douglas, MD, PhD: State of Thyroid Eye Disease in 2020
19 Oct 2020
Contributed by Lukas
Raymond Douglas, MD, PhD, discusses trends in therapies and the current state of thyroid eye disease treatments in 2020.
Muthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs
08 Oct 2020
Contributed by Lukas
In this episode of the Endocrine Outlook, listeners will hear a conversation with Muthiah Vaduganathan, MD, MPH, a cardiologist at Brigham and Women’...
Prof. Hiddo Heerspink: Insights from DAPA-CKD
01 Sep 2020
Contributed by Lukas
In this special edition episode of the Endocrine Outlook, you will hear from Professor Hiddo Heerspink. Heerspink recently presented results of th...
Joshua Denson, MD: Metabolic Syndrome and COVID-19 Outcomes
01 Sep 2020
Contributed by Lukas
In this episode of the endocrine outlook, you will hear from Dr. Joshua Denson of Tulane University Medicine. In the episode, we discuss the results o...
Robert Busch, MD: Topline Results of EMPEROR-REDUCED
31 Jul 2020
Contributed by Lukas
In this episode we will be discussing reaction to topline results from the EMPEROR-REDUCED trial examining the use of empagliflozin for heart failure ...
Diabetes Research & COVID-19
31 Jul 2020
Contributed by Lukas
In this episode you’ll hear my interview with Dr. Jamie Hartmann-Boyce, senior research fellow and departmental lecturer at the Nuffield Department ...